Exploration of Patient Self-medication Practices During and After Cancer in France: Cross-sectional Observational Study With Online Response

University Hospital, Clermont-Ferrand1 site in 1 country681 target enrollmentDecember 14, 2021

ConditionsCancer Self-medication

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cancer
Sponsor: University Hospital, Clermont-Ferrand
Enrollment: 681
Locations: 1
Primary Endpoint: Self-medication
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to assess the patient self-medication practices during and after cancer in France, using an online questionnaire

Detailed Description

Patients will be contacted by email from patient's associations. Patients will be informed of the objectives of the study and will be free to answer or not to the online questionnaire.

Registry

clinicaltrials.gov

Start Date

December 14, 2021

End Date

April 30, 2022

Last Updated

3 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

University Hospital, Clermont-Ferrand

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Past or active cancer

Exclusion Criteria

•Speaking French
•Not living in France

Outcomes

Primary Outcomes

Self-medication

Time Frame: day 1

declaration of a practice of self-medication

Secondary Outcomes

Class of products used in self-medication(day 1)
Origin of self-medication products(day 1)
Perception of adverse effects and drug-drug interaction related to self medication(day 1)
QLQ-C30 questionnaire(day 1)
Indication for self-medication(day 1)